Leukocytes contain both nicotinic and muscarinic receptors, and while activation of nicotinic receptors suppresses immune/inflammatory responses, the role of muscarinic receptors in immunity is unclear. We examined the effects of a muscarinic receptor antagonist (atropine) and agonist (oxotremorine), administered chronically through miniosmotic pumps, on immune/inflammatory responses in the rat. Results show that while oxotremorine stimulated, atropine inhibited the antibody and T-cell proliferative responses. Moreover, atropine also suppressed the turpentine-induced leukocytic infiltration and tissue injury, and inhibited chemotaxis of leukocytes toward neutrophil and monocyte/lymphocyte chemoattractants. Thus, activation of nicotinic and muscarinic receptors has opposite effects on the immune/inflammatory responses.
Introduction
The nervous system and the immune system communicate bidirectionally, and lymphoid tissues are innervated by the autonomic nervous system (Blalock, 1994) . However, increasing evidence suggests the presence of a non-neuronal cholinergic system on many cell types, in particular, the immunocompetent cells at the site of inflammation (Kurzen et al., 2007) . Cells of the immune system contain most components of the cholinergic system, including choline acetyltransferase, choline transporters, and acetylcholinesterase, and they produce acetylcholine (Kawashima and Fujii, 2004) . In addition, lymphocytes contain both muscarinic receptors (mAChRs) and nicotinic receptors (nAChRs) (Bering et al., 1987; Kawashima and Fujii, 2004; Razani-Boroujerdi et al., 2007) . Therefore, it is likely that the cholinergic system on immune cells plays a role in regulating the immune responses. Indeed, activation of nAChRs, either through direct interaction with nicotinic agonists or indirectly through activation of the autonomic and vagal systems, inhibits adaptive and innate immune responses (Sopori, 2002; Czura et al., 2003; Ulloa, 2005) . Moreover, chronic nicotine administration increases the lung burden of influenza virus (Razani-Boroujerdi et al., 2004) and Cryptococcus neoformans (Razani-Boroujerdi et al., unpublished). Thus, activation of nicotinic receptors suppresses the immune system and increases the susceptibility to pathogenic infections.
The role of muscarinic receptors in modulating the immune system is not clear. Vagotomy and atropinization moderate lethal anaphylaxis and histamine shock (Levy et al., 1976) , and carbacholine increases the number of leukocytes in the splenic venous blood that is blocked by atropine treatment (Sandberg, 1994) . Direct addition of acetylcholine to spleen cell cultures enhances the Con A-induced T-cell proliferation (Qiu et al., 1996) . Therefore, activation of mAChRs may activate the immune system. However, because acetylcholine can react with both nicotinic and muscarinic receptors, it is difficult to ascertain whether the effects reflect its interaction with muscarinic and/or nicotinic receptors. In this study, we used selective muscarinic agonists/antagonists to show that while mAChR agonists stimulate, mAChR antagonists inhibit Journal of Neuroimmunology 194 (2008) 83 -88 www.elsevier.com/locate/jneuroim
